Don Matz

Don Matz joined Raymond James as a managing director covering the pharma services & outsourcing sector in 2022. With over fifteen years of investment banking experience, Mr. Matz has executed M&A and equity transactions for clients that deliver innovative services and technologies across the drug development continuum. Previously, Mr. Matz worked at SVB Leerink where he was also focused on advising clients within the pharma services & outsourcing sector. Prior to SVB Leerink, he held healthcare investment banking roles at Lazard and Leerink Swann, working on a variety of advisory and corporate finance transactions. He began his career at Benfield Advisory. Mr. Matz received his Bachelor of Science in Business Administration from Carnegie Mellon University.